Prognon P - Search Results

1

Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.

Caudron E, Prognon P, Germain DP. Caudron E, et al. Among authors: prognon p. Eur J Med Genet. 2015 Dec;58(12):681-4. doi: 10.1016/j.ejmg.2015.10.014. Epub 2015 Oct 28. Eur J Med Genet. 2015. PMID: 26520229

2

Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.

Hagège AA, Caudron E, Damy T, Roudaut R, Millaire A, Etchecopar-Chevreuil C, Tran TC, Jabbour F, Boucly C, Prognon P, Charron P, Germain DP; FOCUS study investigators. Hagège AA, et al. Among authors: prognon p. Heart. 2011 Jan;97(2):131-6. doi: 10.1136/hrt.2010.200188. Epub 2010 Nov 9. Heart. 2011. PMID: 21062768

3

[Laboratory diagnosis of Fabry disease: historical perspectives and recent breakthroughs].

Caudron É, Roy S, Germain DP, Chaminade P, Prognon P. Caudron É, et al. Among authors: prognon p. Presse Med. 2007 Mar;36 Spec No 1:1S76-81. Presse Med. 2007. PMID: 17546773 Review. French.

4

Rapid discrimination and quantification analysis of five antineoplastic drugs in aqueous solutions using Raman spectroscopy.

Lê LMM, Berge M, Tfayli A, Zhou J, Prognon P, Baillet-Guffroy A, Caudron E. Lê LMM, et al. Among authors: prognon p. Eur J Pharm Sci. 2018 Jan 1;111:158-166. doi: 10.1016/j.ejps.2017.09.046. Epub 2017 Sep 29. Eur J Pharm Sci. 2018. PMID: 28966101

5

Forced Degradation of Monoclonal Antibodies After Compounding: Impact on Routine Hospital Quality Control.

Jaccoulet E, Daniel T, Prognon P, Caudron E. Jaccoulet E, et al. Among authors: prognon p. J Pharm Sci. 2019 Oct;108(10):3252-3261. doi: 10.1016/j.xphs.2019.06.004. Epub 2019 Jun 13. J Pharm Sci. 2019. PMID: 31201907

6

Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease.

Touboul D, Roy S, Germain DP, Baillet A, Brion F, Prognon P, Chaminade P, Laprévote O. Touboul D, et al. Among authors: prognon p. Anal Bioanal Chem. 2005 Jul;382(5):1209-16. doi: 10.1007/s00216-005-3239-8. Epub 2005 Jun 16. Anal Bioanal Chem. 2005. PMID: 15959771

7

Comparative analysis of methods for real-time analytical control of chemotherapies preparations.

Bazin C, Cassard B, Caudron E, Prognon P, Havard L. Bazin C, et al. Among authors: prognon p. Int J Pharm. 2015 Oct 15;494(1):329-36. doi: 10.1016/j.ijpharm.2015.08.041. Epub 2015 Aug 20. Int J Pharm. 2015. PMID: 26299761 Review.

8

Discriminative and Quantitative Analysis of Antineoplastic Taxane Drugs Using a Handheld Raman Spectrometer.

Lê L, Berge M, Tfayli A, Prognon P, Caudron E. Lê L, et al. Among authors: prognon p. Biomed Res Int. 2018 Jul 3;2018:8746729. doi: 10.1155/2018/8746729. eCollection 2018. Biomed Res Int. 2018. PMID: 30065947 Free PMC article.

9

Safety analysis of occupational exposure of healthcare workers to residual contaminations of cytotoxic drugs using FMECA security approach.

Le LMM, Reitter D, He S, Bonle FT, Launois A, Martinez D, Prognon P, Caudron E. Le LMM, et al. Among authors: prognon p. Sci Total Environ. 2017 Dec 1;599-600:1939-1944. doi: 10.1016/j.scitotenv.2017.05.066. Epub 2017 May 23. Sci Total Environ. 2017. PMID: 28549369

10

Discriminative and quantitative analysis of norepinephrine and epinephrine by surface-enhanced Raman spectroscopy with gold nanoparticle suspensions.

Dowek A, Berge M, Prognon P, Legrand FX, Larquet E, Tfayli A, Lê LMM, Caudron E. Dowek A, et al. Among authors: prognon p. Anal Bioanal Chem. 2022 Jan;414(2):1163-1176. doi: 10.1007/s00216-021-03743-4. Epub 2021 Oct 31. Anal Bioanal Chem. 2022. PMID: 34718838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters